跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COMBOVAL 10 MG/ML + 3 MG/ML SOLUCIÓN PARA PERFUSIÓN - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
COMBOVAL 10 MG/ML + 3 MG/ML SOLUCIÓN PARA PERFUSIÓN
Approved
STANDARD
COMBOVAL 10 MG/ML + 3 MG/ML SOLUCIÓN PARA PERFUSIÓN
Laboratoire Aguettant
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 31, 2023
Approval ID
880d38254b05704c
Company
Laboratoire Aguettant
Type
Standard
Approval Details
Approval Id
880d38254b05704c
Drug Cima Aemps Name
COMBOVAL 10 MG/ML + 3 MG/ML SOLUCIÓN PARA PERFUSIÓN
Register Number
87269
Holder Company Name
Laboratoire Aguettant
Marketing Company Name
Aguettant Iberica S.L.
Holder Company Detail Path
/organization/laboratoire-aguettant
Authorization Date
2023-08-31
Dosage Form
SOLUCIÓN PARA PERFUSIÓN
Dose
10 mg/ml + 3 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Laboratoire Aguettant
Company Detail Path
/organization/laboratoire-aguettant
Company Information
Pharmaceutical Company Name
Laboratoire Aguettant
Country Name
Belgium
City Name
unknown,country_be
Address
Unknown Belgian address
Website
https://www.aguettant.co.uk
Active Ingredients
PARACETAMOL
10 mg/ml
IBUPROFENO SODICO DIHIDRATO
3,85 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 31, 2023
Approval ID
880d38254b05704c
Type
Standard
Back to CIMA-AEMPS Approvals
